1. Current Therapy for Type II Diabetes1

4. 4

8. Core Concept: The choice of diabetes therapies needs to be individualized based on quality attributes that fit with patient needs.
The choice of diabetes therapies must be individualized based on attributes specific to patients and the medications themselves. Medication attributes that affect their choice include: risk of inducing hypoglycemia, risk of weight gain, ease of use, cost, and safety impact for heart, kidney, or liver disease. This table published by the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) includes every U.S. Food and Drug Administration (FDA)-approved class of medications for diabetes.
Reference
Garber AJ, Abrahamson MJ, Barzilay JI, et al. American Association of Clinical Endocrinologists’ comprehensive diabetes management algorithm 2013 consensus statement. Endocr Pract. 2013;19(suppl 2):1-48.

9. New